Teplizumab 2mg/2ml solution for infusion vials
- SNOMED code
45412811000001100- Active compound
- Teplizumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 2 ml, vial
- Ingredients
- Teplizumab
— 1 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Tzield 2mg/2ml concentrate for solution for infusion vials (Sanofi)
Tzield 2mg/2ml concentrate for solution for infusion vials
- SNOMED code
45410011000001107- Supplier
- Sanofi
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Tzield 2mg/2ml concentrate for solution for infusion vials (Sanofi) 1 vial45410411000001103 ref. pack | 💯 Available Legal category: POM | 5000283663379 | NHS Indicative Price £10,939 | • Hospital |
| — |
Reference packs
Teplizumab 2mg/2ml solution for infusion vials 1 vial
- SNOMED code
45409911000001102- Quantity and unit
- 1 vial
- Packs